ELI LILLY AND COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 897.2 USD | -1.05% |
|
-0.35% | +54.07% |
| 05:38pm | Global markets live: Eli Lilly, Apple, Walmart, Shell, Rio Tinto... |  |
| 01:47pm | Stocks to watch as Biden and Trump vie for presidency | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
08/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
906.7
USD
Average target price
870.3
USD
Spread / Average Target
-4.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +54.07% | 816B | |
| +38.59% | 634B | |
| -7.05% | 351B | |
| +15.44% | 323B | |
| +5.72% | 293B | |
| +13.40% | 238B | |
| +0.61% | 222B | |
| +13.24% | 218B | |
| +7.42% | 167B | |
| -3.79% | 158B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly, Radionetics Oncology Strike Strategic Agreement
